Prospective double blind randomized clinical trial comparing 75% versus 95% silver nitrate cauterization in the management of idiopathic childhood epistaxis

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 1, 2011, Pages 81-84

  Glynn, F ^a   Amin, M ^a   Sheahan, P ^a   Mc Shane, D ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Cauterization; Childhood; Epistaxis; Nitrate; Silver

Indexed keywords

SILVER NITRATE;

ADOLESCENT; ARTICLE; CAUTERIZATION; CHILD; CONCENTRATION RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPISTAXIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE DISEASE; NOSE SEPTUM PERFORATION; NOSE SEPTUM TATTOOING; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TISSUE NECROSIS; VISUAL ANALOG SCALE; VON WILLEBRAND DISEASE;

ADOLESCENT; CAUTERY; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; EPISTAXIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE; REFERENCE VALUES; REOPERATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SILVER NITRATE; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650994877     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2010.10.014     Document Type: Article

References (14)

1. Petruson B. Epistaxis in childhood. Rhinology 1979, 17:83-90.
2. Josephson G.D., Godley F.A., Stierna P. Practical management of epistaxis. Med Clin North Am 1991, 75:1311-1320.
3. Barr G.D. Silver nitrate cautery and epistaxis. Arch Emerg Med 1989, 6:233.
4. Randall D.A., Freeman S.B. Management of anterior and posterior epistaxis. Am Fam Physician 1991, 43:2007-2014.
5. Parker A.J., Clegg R.T. How to control epistaxis. Br J Hosp Med 1990, 44:198-200.
6. Wurman L.H., Sack J.G., Flannery J.V., Lipsman R.A. The management of epistaxis. Am J Otolaryngol 1992, 13:193-209.
7. Hanif R.A., Tasca A., Frosh K., Ghufoor K., Stirling R. Silver nitrate: histological effects of cautery on epithelial surfaces with varying contact times. Clin Otol 2003, 28:368-370.
8. Murthy P., Laing M.R. An unusual severe adverse reaction to silver nitrate cautery for epistaxis in an immuno-compromised patient. Rhinology 1996, 34:186-187.
9. Mayall F., Wild D. A silver tattoo of the nasal mucosa after silver nitrate cautery. J Laryngol Otol 1996, 110:609-610.
10. Watkinson J.C. Epistaxis. Scott-Brown's otolaryngology 1997, vol. 4, Rhinology. Butterworth-Heinemann, Oxford, 4/18/1-19. 6th ed.
11. Ruddy J., Proops D.W., Pearman K., Ruddy H. Management of epistaxis in children. Int J Pediatr Otorhinolaryngol 1991, 21:139-142.
12. Murthy P., Nilssen E.L.K., Rao S., McClymont L.G. A randomised clinical trial of antiseptic nasal carrier cream and silver nitrate cautery in the treatment of recurrent anterior epistaxis. Clin Otol 1999, 24:228-231.
13. Calder N., Kang S., Fraser L., Kunanandam T., Montgomery J., Kubba H. A double blind randomised control trial of management of recurrent nosebleeds in children. Otolaryngol Head Neck Surg 2009, 140(5):670-674. May.
14. Amin M., Glynn F., Sheahan P., Phelan S., Crotty P., Mc Shane D. Silver nitrate cauterization, does concentration matter?. Clin Otol 2007, 32(3):197-199.